GeneDx Holdings Corp. Increase (Decrease) in Contract with Customer, Liability
GeneDx Holdings Corp. (WGS) reported Increase (Decrease) in Contract with Customer, Liability of $0 for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2023-08-08
- GeneDx Holdings Corp. increase (decrease) in contract with customer, liability for the quarter ending 2023-06-30 was $0.00.
- GeneDx Holdings Corp. increase (decrease) in contract with customer, liability for the quarter ending 2023-03-31 was $0.00.
- GeneDx Holdings Corp. increase (decrease) in contract with customer, liability for the quarter ending 2022-12-31 was $40.00K.
- GeneDx Holdings Corp. increase (decrease) in contract with customer, liability for the quarter ending 2022-09-30 was $0.00.
- GeneDx Holdings Corp. increase (decrease) in contract with customer, liability for fiscal 2022 was -$433.00K.
- GeneDx Holdings Corp. increase (decrease) in contract with customer, liability for fiscal 2021 was -$1.31M.
- GeneDx Holdings Corp. increase (decrease) in contract with customer, liability for fiscal 2020 was -$559.00K, a 123.87% decline from fiscal 2019.
- GeneDx Holdings Corp. increase (decrease) in contract with customer, liability for fiscal 2019 was $2.34M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $40.00K derived: sum of 3 quarters · filed 2023-08-08 | $40.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $40.00K derived: sum of 2 quarters · filed 2023-05-09 | $40.00K derived: sum of 3 quarters · filed 2023-05-09 | -$25.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $40.00K derived: sum of 2 quarters · filed 2023-03-16 | -$25.00K derived: sum of 3 quarters · filed 2023-08-08 | -$433.00K 10-K · filed 2023-03-16 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$65.00K derived: sum of 2 quarters · filed 2023-08-08 | -$473.00K 10-Q · filed 2022-11-14 | -$493.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-06-30 | -$65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$473.00K 10-Q · filed 2023-08-08 | -$493.00K derived: sum of 3 quarters · filed 2023-08-08 | -$1.34M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$408.00K 10-Q · filed 2023-05-09 | -$428.00K derived: sum of 2 quarters · filed 2023-05-09 | -$1.28M derived: sum of 3 quarters · filed 2023-05-09 | -$2.75M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$868.00K derived: sum of 2 quarters · filed 2023-03-16 | -$2.34M derived: sum of 3 quarters · filed 2023-03-16 | -$1.31M 10-K · filed 2023-03-16 |
| 2021-09-30 | -$848.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$2.32M derived: sum of 2 quarters · filed 2022-11-14 | -$1.29M 10-Q · filed 2022-11-14 | -$1.71M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | -$1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$442.00K 10-Q · filed 2022-08-15 | -$866.00K derived: sum of 3 quarters · filed 2023-03-16 | |
| 2021-03-31 | $1.03M 10-Q · filed 2022-05-12 | $603.00K derived: sum of 2 quarters · filed 2023-03-16 | ||
| 2020-12-31 | -$424.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$559.00K 10-K · filed 2023-03-16 | ||
| 2020-09-30 | -$135.00K 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | $2.34M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |